Eqis Capital Management, Inc. Palatin Technologies Inc Transaction History

Eqis Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 25, 2019	SELL	$0.63 - $1.0 $10,818 - $17,173	-17,173 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$0.88 - $1.1 $830 - $1,038	944 Added 5.82%	17,173 $18,000
Q2 2018 Jul 27, 2018	BUY	$0.91 - $1.45 $14,768 - $23,532	16,229 New	16,229 $16,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.